SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Dare Bioscience Q1 EPS $(0.180) Beats $(0.290) Estimate

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.180) per share which beat the analyst consensus estimate of $(0.290) by 37.93 percent. This is a 33.33 percent increase over losses of $(0.270) per share

Benzinga · 05/14/2020 12:11

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.180) per share which beat the analyst consensus estimate of $(0.290) by 37.93 percent. This is a 33.33 percent increase over losses of $(0.270) per share from the same period last year.